Skip to main content
logo
Keymed Biosciences Inc. (HKG:2162)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
77.75
+0.70 (0.91%)
Aug 20, 2026, 4:09 PM HKT

Keymed Biosciences Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
834.63716.31428.12354.1100.06110.27
Revenue Growth
16.52%67.31%20.91%253.87%-9.26%-
Gross Profit
660.11627.06415.92317.2297.4893.07
Operating Income
-679.3-631.05-626.09-457.43-544.49-360.5
Net Income
773.65-522.64-515.24-359.36-308.12-3,887
Earnings Per Share
2.71-1.91-1.97-1.37-1.18-24.17
EPS Growth
------

Revenue by Geography
Chart
Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
United States of America
393.67335.01---
Mainland China
322.1736.970.9100.06110.27
United Kingdom
0.4756.14---
Total
716.31428.12354.1100.06110.27

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3,2271,9242,1562,7193,1753,525
Total Debt
696.69788.54753.24418.71122.1939.26
Net Cash (Debt)
2,5311,1351,4022,3003,0533,485
Net Cash Growth
122.91%-19.05%-39.04%-24.65%-12.40%-
Net Cash Per Share
8.854.145.358.8011.6921.67

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--712.41-789.63-303.62-401.93-214.64
Capital Expenditures
--333.92-207.91-378.49-278.82-171.79
Free Cash Flow
--1,046-997.55-682.11-680.76-386.42
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
79.09%87.54%97.15%89.59%97.42%84.40%
Operating Margin
-81.39%-88.10%-146.24%-129.18%-544.15%-326.93%
Pretax Margin
127.33%-72.69%-118.81%-100.59%-303.41%-3530.12%
Profit Margin
92.69%-72.96%-120.35%-101.49%-307.92%-3525.30%
FCF Margin
--146.07%-233.00%-192.63%-680.33%-350.44%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
23.7719.7518.6934.83125.3071.30